This article explores new cosmetic ingredient identifications and adjustments in the Asia-Pacific regions. China, Taiwan, South Korea, Indonesia, Malaysia, Vietnam and New Zealand regulatory changes throughout 2023 and into 2024 are discussed.
Immunogenicity and safety of an E coli-produced human papillomavirus vaccine: A phase 2 controlled trial medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
This article provides regulatory updates primarily in China and India, as well as Thailand and South Korea. Topics include formula submissions, new ingredients/safety, Korean standards, India cosmetics rules, licenses to operate in the Philippines and more.
Kedrion s global portfolio expands to China to supply human Albumin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.